http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2271001-C1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2004-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_064a64e411cc2d225466a2fcfde7ced4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f664dbb639d7ecd4560a22df1e97a113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdec888e6f9eb76c32f745a7b8bc93bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_788ed3c778085c983d73ba3a605bb4dd |
| publicationDate | 2006-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2271001-C1 |
| titleOfInvention | Express method for identifying pharmaceutics and parapharmaceutics introduced into human organism |
| abstract | FIELD: medicine. n SUBSTANCE: method involves scanning pulse with glass plate placed on pulse measurement point. The glass plate bears biological test system containing composition of 0.1% aqueous amino acid solutions like tryptophan, aspartic acid, alanine, treonine, valine, serine, glycine and tyrosine taken in equal proportions, 0.5% aqueous solution of dopamine, 0.5% aqueous solution of histamine, 12% aqueous solution of magnesium sulfate taken in 3:3:13 proportion. The plate is hold on pulse for 1-2 min before and 10-15 min after giving the pharma- or parapharmaceutic under study to a patient. Then, the plate is dried at T=+18-20°C during 2-3 min and another glass plate is covered with biological test system surrounded with wall of the pharma- or parapharmaceutic under study arranged along periphery and dried at T=+18-20°C during 2-3 min. The biological test system structures formed on the plates are compared in polarized light with quartz compensator. Structural similarity being detected, identification of pharma- or parapharmaceutic introduced into human organism is to be recorded. n EFFECT: enhanced effectiveness in identifying biologically active substances introduced into human organism. n 26 dwg |
| priorityDate | 2004-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.